US Patent Issued to ASCENDIS PHARMA ONCOLOGY DIVISION on March 3 for "IL-2 conjugates" (Danish, German Inventors)

ALEXANDRIA, Va., March 3 -- United States Patent no. 12,565,525, issued on March 3, was assigned to ASCENDIS PHARMA ONCOLOGY DIVISION A/S (Hellerup, Denmark).

"IL-2 conjugates" was invented by Kennett Sprogoe (Hellerup, Denmark), Harald Rau (Heidelberg, Denmark), Thomas Knappe (Heidelberg, Germany), Nicola Bisek (Heidelberg, Germany) and Burkhardt Laufer (Heidelberg, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to IL-2 conjugates, a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising such IL-2 conjugate or a pharmaceutically acceptable salt thereof and their uses."

The patent was filed on March 27, 2019, under Application No. 17/042,610. ...